These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 20978205)

  • 1. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
    Cho WC; Chow AS; Au JS
    Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor.
    Liu L; Shao X; Gao W; Zhang Z; Liu P; Wang R; Huang P; Yin Y; Shu Y
    FEBS J; 2012 Oct; 279(20):3800-12. PubMed ID: 22883469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of miRNAs that target EGFR mRNA in human lung cancer.
    Yamaguchi G; Takanashi M; Tanaka M; Fujita K; Ohira T; Kuroda M; Ikeda N
    Biochem Biophys Res Commun; 2012 Apr; 420(2):411-6. PubMed ID: 22426479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
    Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRS2beta, a potential prognostic gene for non-small cell lung cancer, encodes a feedback inhibitor of EGF receptor family members by ERK binding.
    Iejima D; Minegishi Y; Takenaka K; Siswanto A; Watanabe M; Huang L; Watanabe T; Tanaka F; Kuroda M; Gotoh N
    Oncogene; 2010 May; 29(21):3087-99. PubMed ID: 20228838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
    Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
    Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
    Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
    Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
    Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
    Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer.
    Zhang Z; Chen Z; Song Y; Zhang P; Hu J; Bai C
    J Pathol; 2010 Jun; 221(2):210-20. PubMed ID: 20455256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z; Ge L; Wang M; Carr BI
    J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.
    Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N
    Int J Oncol; 2010 Nov; 37(5):1315-21. PubMed ID: 20878079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer.
    Zhong M; Ma X; Sun C; Chen L
    Chem Biol Interact; 2010 Mar; 184(3):431-8. PubMed ID: 20097187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
    Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
    Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.